46 results
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
Guideline for the Management ... #HeartFailure #Management ... #CHF #guideline ... #ACCAHA2017 #cardiology ... #treatment #algorithm
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
Diagnosis and Treatment ... iron #deficiency #CHF ... heartfailure #diagnosis #management ... #algorithm #cardiology ... #treatment #guidelines
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Treatment of Stable ... with caution in pulmonary ... disease or CHF) ... disease or CHF) ... #management #cardiology
Treatment options for patients with Chronic Symptomatic Systolic Heart Failure

#sCHF #CongestiveHeartFailure #Systolic #HFrEF #Algorithm #Management #Cardiology
Treatment options ... Heart Failure #sCHF ... HFrEF #Algorithm #Management ... #Cardiology #ivabradine
Heart Failure with Preserved Ejection Fraction: Management Principles

General Therapeutic Principles:
Reduce the congestive state 
 - Caution
Ejection Fraction: Management ... hypertension, pulmonary ... ineffective) #Management ... #Cardiology #HFpEF ... #Treatment #HeartFailure
Iron Deficiency in Congestive Heart Failure (CHF)

Iron deficiency (ID) in heart failure is a common comorbidity
Heart Failure (CHF ... Ferritin < 100 ng/mL ... Ferritin 100 - 299 ng/mL ... depot iron] Treatment ... pathophysiology #cardiology
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
development of HF ... ventricular hypertrophy; MCS ... #CHF #Congestive ... ACCAHA #Algorithm #Management ... #Cardiology
STAGES of CHF (A, B, C, D), however, describe the severity of structural abnormalities that impair
STAGES of CHF (A ... sometimes advanced treatment ... Treatments may include ... #Management #Cardiology ... #CHF #Congestive
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
Management of interstitial ... >10% (or >200 mL ... DLCO >15% (or 3 mL ... systemicsclerosis #SSc #pulmonary ... #indications #management
Algorithm for Treatment of Chronic Thromboembolic Disease (CTEPH)
Initial Imaging for Screening - V/Q scan - 90-100%
Algorithm for Treatment ... • Assess for Pulmonary ... karanpdesai #cteph #management ... #algorithm #cardiology ... #pulmonary #treatment